Improving Genetic Counseling for BRCA+ Mothers
改善 BRCA 母亲的遗传咨询
基本信息
- 批准号:10557851
- 负责人:
- 金额:$ 23.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-02 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:2 arm randomized control trialAddressAdolescent and Young AdultAdoptionAdultAdult ChildrenAftercareAgeAllyAnxietyAreaAwarenessBRCA mutationsBehavior TherapyBehavioralBloodBreastCancer ControlCaregiversCaringChildChild RearingClinicalCognitiveCollaborationsCommunicationCommunitiesComplexConflict (Psychology)Coping SkillsCounselingCritical CareDataDaughterDecision MakingDisclosureDistressEducational process of instructingEmotionalFaceFamilyFamily history ofFeelingFemale AdolescentsFutureGene MutationGenesGeneticGenetic CounselingGoalsGuiltHealthHealthy People 2020Hereditary Malignant NeoplasmInheritedInterventionKnowledgeMalignant NeoplasmsMalignant neoplasm of ovaryManualsMediatingMedicalMental DepressionModelingMonitorMothersNotificationOncologyOperative Surgical ProceduresOutcomeParentsParticipantPatientsPilot ProjectsPopulation GeneticsPredispositionPreventionProliferatingProtocols documentationPsychosocial Assessment and CarePublic HealthPublic Health PracticeRandomizedReportingResourcesRiskRisk ReductionSelf EfficacySelf ManagementService delivery modelSiblingsSiteSonStressStructureTest ResultTestingThinkingTimeTrainingUncertaintyWell in selfWomanWorkanticancer researcharmbrca genecancer geneticscancer preventioncancer riskcommunication aidcommunication behaviorcopingefficacy testingevidence baseexperiencegenetic counselorgenetic informationgenetic testinggenomic toolshealth goalshigh riskimprovedintergenerationalkindredlifetime riskmalignant breast neoplasmmembermutation carrierpeerpeer coachingpeer supportpreferencepreventpsychological distresspsychosocialrandomized trialrecruitresponsescreeningskillssocialstandard caretelephone coachingtelephone sessiontreatment as usual
项目摘要
Women carrying deleterious BRCA mutations are expected to notify their relatives about the family's inherited
cancer susceptibility. This is important because relatives have a 50% chance of harboring the same cancer-
causing genes, and may themselves be at risk for breast and other cancers. Patients sometimes collaborate with
a genetic counselor to follow this advice—disclosing their BRCA+ status to parents, adult siblings, and
additional members of their kindred. Evidence suggests women with children also want to inform their
daughters and sons about maternal BRCA+ genetic test results, but carrier mothers are often psychologically
distressed after testing and have difficulty navigating the social and medical implications for their adolescent
and young adult (AYA) offspring. It is common for these mothers to experience uncertainty over early
notification of BRCA+ to AYAs, manage their own thoughts/feelings about familial cancer, and maintain open
the lines of communication with relatives without `keeping secrets' from their own children. Although genetic
counseling assists with aspects of this decisional and psychosocial burden, there are no evidence-based
resources specifically devoted to ameliorating mothers' anxiety/depression, worry, and self-blame and traverse
complex questions surrounding BRCA+ status notification to their AYAs. In response to this gap, we developed
and successfully piloted a new, fully manualized psychosocial support and family communication decision
making protocol for BRCA+ mothers with AYA children. Our intervention is theoretically-grounded, and
deeply attends to self-management needs, hereditary cancer stresses, and age-appropriate AYA concerns.
Following standard genetic counseling, it adds 3 sessions of brief telephone counseling delivered by well-
trained peers (parent coaches) who are also BRCA+ mothers themselves. Coaching covers: a) maternal
socioemotional support, b) communication decision making training, and c) coping skill-building. We will
rigorously test for efficacy in a 2-arm RCT to determine improvements in maternal psychosocial functioning
and parent-AYA child communication outcomes after standard genetic counseling. BRCA+ mothers with AYA
daughters and sons will be recruited from cancer genetic testing centers in the greater DC and Hackensack, NJ
areas, randomized to an intervention or usual care control condition, and monitored for up to 6 months post-
treatment. Our results should provide evidence for favorably impacting this population's genetic counseling
outcomes, with a disseminable intervention poised for adoption. Peer support may be conventional within the
breast cancer community at-large, but it remains an unproven treatment ally in genetically informed oncology
care. The proliferation of genetic tests, and the modest genetic counseling workforce, necessitate new
healthcare delivery models that leverage these and other accessible resources. Targeted peer coaching with an
empirical decision support aide could prove to be a viable extension of genetic counseling efforts with BRCA+
mothers, and a complementary approach to hereditary cancer prevention and control in public health settings.
携带有害的BRCA突变的妇女应该通知她们的亲属家族遗传的情况
癌症易感性。这一点很重要,因为亲属患上同样的癌症的可能性为50%。
导致基因,本身可能有患乳腺癌和其他癌症的风险。患者有时会与
遗传咨询师遵循这一建议-向父母、成年兄弟姐妹和
他们的亲属中的其他成员。有证据表明,有孩子的女性也希望告知她们的
女儿和儿子对母亲BRCA+基因检测结果的了解,但携带者母亲往往心理上
在测试后感到苦恼,难以领会青少年的社会和医学影响
和年轻的成年(Aya)后代。对于这些母亲来说,早早经历不确定是很常见的
将BRCA+通知给AYA,管理自己对家族性癌症的想法/感受,并保持开放
与亲人的沟通渠道,而不对自己的孩子“保守秘密”。虽然基因
咨询帮助这种决策和心理社会负担的方面,没有基于证据的
专门用于改善母亲焦虑/抑郁、担心、自责和自责的资源
围绕BRCA+向其AYA发送状态通知的复杂问题。为了应对这一差距,我们开发了
并成功地试行了一项新的、完全人性化的心理社会支持和家庭沟通决策
为BRCA+有Aya孩子的母亲制定方案。我们的干预是有理论依据的,而且
深入关注自我管理需求、遗传性癌症压力和与年龄相适应的Aya问题。
继标准的遗传咨询之后,它增加了由Well-Well提供的3次简短的电话咨询
训练有素的同龄人(家长教练),他们本身也是BRCA+母亲。辅导范围:a)产妇
社会情感支持,b)沟通决策培训,c)应对技能建设。我们会
严格测试双臂随机对照试验的有效性,以确定母亲心理社会功能的改善
以及标准遗传咨询后的亲子沟通结果。BRCA+患有Aya的母亲
女儿和儿子将从新泽西州大哥伦比亚特区和哈肯萨克的癌症基因检测中心招募
地区,随机到干预或通常护理控制条件,并监测长达6个月后-
治疗。我们的结果应该为有利地影响这一人群的遗传咨询提供证据
结果,并准备采用可传播的干预措施。同行支持可能是传统的
广泛的乳腺癌社区,但在基因信息肿瘤学中,它仍然是一个未经证实的治疗盟友
关心。基因测试的激增,以及适度的遗传咨询劳动力,需要新的
利用这些资源和其他可访问资源的医疗保健提供模式。通过有针对性的同行辅导
经验性决策支持助手可能被证明是BRCA+遗传咨询努力的可行扩展
在公共卫生环境中对遗传性癌症的预防和控制采取一种补充办法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BETH N PESHKIN其他文献
BETH N PESHKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BETH N PESHKIN', 18)}}的其他基金
Improving Genetic Counseling for BRCA+ Mothers
改善 BRCA 母亲的遗传咨询
- 批准号:
10337055 - 财政年份:2020
- 资助金额:
$ 23.68万 - 项目类别:
Improving Genetic Counseling for BRCA+ Mothers
改善 BRCA 母亲的遗传咨询
- 批准号:
10079017 - 财政年份:2020
- 资助金额:
$ 23.68万 - 项目类别:
Improving Genetic Counseling for BRCA+ Mothers
改善 BRCA 母亲的遗传咨询
- 批准号:
10292670 - 财政年份:2020
- 资助金额:
$ 23.68万 - 项目类别:
Improving Genetic Counseling for BRCA+ Mothers
改善 BRCA 母亲的遗传咨询
- 批准号:
10524155 - 财政年份:2020
- 资助金额:
$ 23.68万 - 项目类别:
Improving Genetic Counseling for BRCA+ Mothers
改善 BRCA 母亲的遗传咨询
- 批准号:
9885317 - 财政年份:2020
- 资助金额:
$ 23.68万 - 项目类别:
BRCA1/2 Education for Mothers and Their Teen Daughters
针对母亲及其青少年女儿的 BRCA1/2 教育
- 批准号:
6955438 - 财政年份:2005
- 资助金额:
$ 23.68万 - 项目类别:
BRCA1/2 Education for Mothers and Their Teen Daughters
针对母亲及其青少年女儿的 BRCA1/2 教育
- 批准号:
7116518 - 财政年份:2005
- 资助金额:
$ 23.68万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.68万 - 项目类别:
Research Grant














{{item.name}}会员




